ATE370131T1 - Verfahren zur herstellung von 5-(1,3-oxazol-2- yl)benzoesäurederivaten - Google Patents

Verfahren zur herstellung von 5-(1,3-oxazol-2- yl)benzoesäurederivaten

Info

Publication number
ATE370131T1
ATE370131T1 AT03761206T AT03761206T ATE370131T1 AT E370131 T1 ATE370131 T1 AT E370131T1 AT 03761206 T AT03761206 T AT 03761206T AT 03761206 T AT03761206 T AT 03761206T AT E370131 T1 ATE370131 T1 AT E370131T1
Authority
AT
Austria
Prior art keywords
sub
oxazole
producing
benzoic acid
acid derivatives
Prior art date
Application number
AT03761206T
Other languages
German (de)
English (en)
Inventor
Michael Reeder
Rick Imbordino
Original Assignee
Pharmacia & Upjohn Co Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia & Upjohn Co Llc filed Critical Pharmacia & Upjohn Co Llc
Application granted granted Critical
Publication of ATE370131T1 publication Critical patent/ATE370131T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/32Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Catalysts (AREA)
AT03761206T 2002-06-20 2003-06-20 Verfahren zur herstellung von 5-(1,3-oxazol-2- yl)benzoesäurederivaten ATE370131T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US39028502P 2002-06-20 2002-06-20
US45047803P 2003-02-27 2003-02-27

Publications (1)

Publication Number Publication Date
ATE370131T1 true ATE370131T1 (de) 2007-09-15

Family

ID=30003150

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03761206T ATE370131T1 (de) 2002-06-20 2003-06-20 Verfahren zur herstellung von 5-(1,3-oxazol-2- yl)benzoesäurederivaten

Country Status (17)

Country Link
US (2) US7115747B2 (enExample)
EP (1) EP1532123B1 (enExample)
JP (1) JP2005533811A (enExample)
CN (1) CN1324017C (enExample)
AT (1) ATE370131T1 (enExample)
AU (1) AU2003249344A1 (enExample)
BR (1) BR0312439A (enExample)
CA (1) CA2489988A1 (enExample)
CO (1) CO5670350A2 (enExample)
DE (1) DE60315664D1 (enExample)
EA (1) EA008389B1 (enExample)
IL (1) IL165763A0 (enExample)
MX (1) MXPA04012630A (enExample)
NO (1) NO20045497L (enExample)
NZ (1) NZ537390A (enExample)
PL (1) PL374999A1 (enExample)
WO (1) WO2004000821A1 (enExample)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006508166A (ja) * 2002-11-27 2006-03-09 イーラン ファーマスーティカルズ、インコーポレイテッド 置換尿素及びカルバメート
TW200738701A (en) * 2005-07-26 2007-10-16 Du Pont Fungicidal carboxamides
US7838676B2 (en) 2005-11-21 2010-11-23 Amgen Inc. Beta-secretase modulators and methods of use
US7872009B2 (en) 2005-11-21 2011-01-18 Amgen Inc. Beta-Secretase modulators and methods of use
JP5274258B2 (ja) 2005-11-21 2013-08-28 アムジエン・インコーポレーテツド β−セクレターゼ調節物質及び使用方法
US7745484B2 (en) * 2005-11-21 2010-06-29 Amgen Inc. Beta-secretase modulators and methods of use
WO2008137168A2 (en) * 2007-05-07 2008-11-13 True Charles W Collapsible, stackable, semi-rigid universal tank for hazardous and non-hazardous goods
ES2436364T3 (es) 2007-05-25 2013-12-30 Amgen Inc. Compuestos de hidroxietilamina sustituidos como moduladores de beta-secretasa y métodos de uso
TW200901991A (en) 2007-05-25 2009-01-16 Amgen Inc Substituted hydroxyethyl amine compounds as beta-secretase modulators and methods of use
US7803809B2 (en) 2008-11-12 2010-09-28 Amgen Inc. Substituted pyrano [2,3-b] pyridinamine compounds as beta-secretase modulators and methods of use
WO2010030954A1 (en) 2008-09-11 2010-03-18 Amgen Inc. Spiro-tetracyclic ring compounds as betasecretase modulators and methods of use
EP2504330A1 (en) 2009-11-23 2012-10-03 Amgen Inc. Amino heteroaryl compounds as beta-secretase modulators and methods of use
EP2504315A1 (en) 2009-11-23 2012-10-03 Amgen Inc. Amino heteroaryl compounds as beta-secretase modulators and methods of use
AU2011207679B2 (en) 2010-01-19 2013-10-10 Amgen Inc. Amino heteroaryl compounds as beta-secretase modulators and methods of use
AU2011227501B9 (en) 2010-03-15 2013-08-22 Amgen Inc. Amino -dihydrooxazine and amino - dihydrothiazine spiro compounds as Beta - secretase modulators and their medical use
EP2547685A1 (en) 2010-03-15 2013-01-23 Amgen Inc. Spiro-tetracyclic ring compounds as beta - secretase modulators
WO2012109165A1 (en) 2011-02-07 2012-08-16 Amgen Inc. 5-amino-oxazepine and 5-amino-thiazepane compounds as beta-secretase antagonists and methods of use
WO2013044092A1 (en) 2011-09-21 2013-03-28 Amgen Inc. Amino-oxazines and amino-dihydrothiazine compounds as beta-secretase modulators and methods of use
US9725469B2 (en) 2012-11-15 2017-08-08 Amgen, Inc. Amino-oxazine and amino-dihydrothiazine compounds as beta-secretase modulators and methods of use
US9462841B1 (en) 2016-03-01 2016-10-11 William Popejoy Protective headgear and shoulder pad apparatus and methods
US11272751B2 (en) 2016-03-01 2022-03-15 Nicholas Popejoy Protective headgear, impact diffusing systems and methods

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20020276A1 (es) 2000-06-30 2002-04-06 Elan Pharm Inc COMPUESTOS DE AMINA SUSTITUIDA COMO INHIBIDORES DE ß-SECRETASA PARA EL TRATAMIENTO DE ALZHEIMER
EP1432674A2 (en) * 2001-10-04 2004-06-30 Elan Pharmaceuticals, Inc. Hydroxypropylamines
CA2466284A1 (en) * 2001-11-08 2003-05-15 Elan Pharmaceuticals, Inc. N, n'-substituted-1,3-diamino-2-hydroxypropane derivatives
GB0325830D0 (en) * 2003-11-05 2003-12-10 Novartis Ag Organic compounds

Also Published As

Publication number Publication date
US20040063965A1 (en) 2004-04-01
WO2004000821A1 (en) 2003-12-31
NO20045497L (no) 2005-03-07
US20070105921A1 (en) 2007-05-10
BR0312439A (pt) 2005-05-10
MXPA04012630A (es) 2005-09-30
NO20045497D0 (no) 2004-12-16
EP1532123B1 (en) 2007-08-15
IL165763A0 (en) 2006-01-15
CO5670350A2 (es) 2006-08-31
CN1324017C (zh) 2007-07-04
JP2005533811A (ja) 2005-11-10
HK1081543A1 (zh) 2006-05-19
CA2489988A1 (en) 2003-12-31
EA008389B1 (ru) 2007-04-27
AU2003249344A1 (en) 2004-01-06
CN1662510A (zh) 2005-08-31
EA200401510A1 (ru) 2005-06-30
NZ537390A (en) 2006-07-28
PL374999A1 (en) 2005-11-14
EP1532123A1 (en) 2005-05-25
DE60315664D1 (de) 2007-09-27
US7115747B2 (en) 2006-10-03

Similar Documents

Publication Publication Date Title
ATE370131T1 (de) Verfahren zur herstellung von 5-(1,3-oxazol-2- yl)benzoesäurederivaten
ATE450523T1 (de) Verfahren zur herstellung von 3-halogen-4,5- dihydro-1 h-pyrazolen
ATE533775T1 (de) Verfahren zur herstellung von 17-vinyl-triflaten als intermediate
ATE404637T1 (de) Verbessertes verfahren und methode zur herstellung von asymmetrischen monofunktionalisierten indocyaninmarkern sowie erhaltene verbindungen
ATE478084T1 (de) Verfahren zur herstellung von 4'- azidocytidinderivaten
ATE331713T1 (de) Verfahren zur herstellung von 5-nitrobenzofuranen
ATE332304T1 (de) Cefdinir salze als zwischenprodukte
DE69816731D1 (de) Benzofuranon-derivate und verfahren zu ihrer herstellung
ATE531702T1 (de) Verfahren zur herstellung von epoxytriazolderivat und zwischenprodukten dafür
DE502004004970D1 (de) Verfahren zur herstellung von oh-geschützten ä4-(2,6-diamino-9h-purin-9-yl)-1,3-dioxolan-2-ylümethanol-derivaten
DE602006021411D1 (de) Verfahren zur herstellung von optional 2-substituierten 1,6-dihydro-6-oxo-4-pyrimidincarboxylsäuren
ATE157647T1 (de) Verfahren zur herstellung von alpha- ketoamidderivaten
ATE477227T1 (de) Verfahren zur herstellung eines trans-4-amino-1- cyclohexancarbonsäurederivats
ATE441627T1 (de) Verfahren zur herstellung von valsartan
ATE496907T1 (de) Verfahren zur herstellung von cilostazol
ATE455087T1 (de) Verfahren zur herstellung von 2,5- dimethylphenylessigsäure
ATE415404T1 (de) Lösungsmittelfreies verfahren zur herstellung von diketopyrrolopyrrol-derivaten
ATE437855T1 (de) (4,5,6,7-tetrahydro-1h-indol-7- yl)essigsäurederivate zur behandlung von alzheimer-krankheit
ATE546432T1 (de) Verfahren zur herstellung von 2- aminomethylpyridin-derivate
ATE282594T1 (de) Verfahren zur herstellung von (+)-trans-4-p- fluorophenyl-3-hydroxymethyl-1-methylpiperidin
ATE390400T1 (de) Verfahren zur herstellung von alpha'-chlorketonen
ATE330612T1 (de) Verfahren zur herstellung von benazeprilhydrochloride
ATE339401T1 (de) Verfahren zur herstellung von alpha-(3-arylthio)- acetophenonen
ATE424397T1 (de) Verfahren zur herstellung von losartanderivaten durch chlorierung und reduktion der entsprechenden 1h-imidazol-5-carbaldehyde
WO2004032854A3 (en) Pharmaceutical compositions for treatment of parkinson's disease

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties